Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Wolf

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
The Journal of Clinical Investigation|December 31, 1997
Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectivelyA B van't Wout, L J Ran, M D de Jong, et al.
HIV Medicine|March 12, 2004
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapyF van Leth, F W N M Wit, P Reiss, et al.
HIV Medicine|June 22, 2010
Late presentation of HIV infection: a consensus definitionA Antinori, T Coenen, D Costagiola, et al.
AIDS (London, England)|December 22, 1999
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyJ M Prins, S Jurriaans, R M van Praag, et al.
Journal of Clinical Immunology|June 14, 2001
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletionR M van Praag, J M Prins, M T Roos, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2001
[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy]M Jambroes, G J Weverling, P Reiss, et al.
AIDS (London, England)|August 26, 1998
The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapyR M Hoetelmans, M H Reijers, G J Weverling, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|March 27, 2015
A Retrospective Cohort Study on the Influence of Comorbidity on Soft Tissue Reactions, Revision Surgery, and Implant Loss in Bone-anchored Hearing ImplantsChristine A den Besten, Rik C Nelissen, Petronella G M Peer, et al.
Lancet (London, England)|September 6, 2003
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studiesG Chêne, J A C Sterne, M May, et al.
Archives of Internal Medicine|September 26, 2001
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort studyP T Nieuwkerk, M A Sprangers, D M Burger, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
The Journal of Clinical Investigation|December 31, 1997
Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectivelyA B van't Wout, L J Ran, M D de Jong, et al.
HIV Medicine|March 12, 2004
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapyF van Leth, F W N M Wit, P Reiss, et al.
HIV Medicine|June 22, 2010
Late presentation of HIV infection: a consensus definitionA Antinori, T Coenen, D Costagiola, et al.
AIDS (London, England)|December 22, 1999
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyJ M Prins, S Jurriaans, R M van Praag, et al.
Journal of Clinical Immunology|June 14, 2001
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletionR M van Praag, J M Prins, M T Roos, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2001
[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy]M Jambroes, G J Weverling, P Reiss, et al.
AIDS (London, England)|August 26, 1998
The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapyR M Hoetelmans, M H Reijers, G J Weverling, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|March 27, 2015
A Retrospective Cohort Study on the Influence of Comorbidity on Soft Tissue Reactions, Revision Surgery, and Implant Loss in Bone-anchored Hearing ImplantsChristine A den Besten, Rik C Nelissen, Petronella G M Peer, et al.
Lancet (London, England)|September 6, 2003
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studiesG Chêne, J A C Sterne, M May, et al.
Archives of Internal Medicine|September 26, 2001
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort studyP T Nieuwkerk, M A Sprangers, D M Burger, et al.
Pageof 19